Oestrogen receptor (ER) analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunocytochemical methods.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0145-2126(90)90106-JPMID 2280609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival

  1989cited by this paper
• Rates and risks of diethylstilbestrol‐related clear‐cell adenocarcinoma of the vagina and cervix. An update

  1988cited by this paper
• Steroid hormones and medications that alter cancer risks

  1988cited by this paper
• Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER.

  1988cited by this paper
• Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States.

  1986cited by this paper
• Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.

  1986cited by this paper
• Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.

  1986cited by this paper
• Comparison of immunochemical and radioligand binding assays for estrogen receptors in human breast tumors.

  1986cited by this paper
• Estrogen and progesterone receptor guideline for tamoxifen therapy in chronic lymphocytic leukemia: a pilot study.

  1986cited by this paper
• Plasmacytoid blast crisis in B-cell chronic lymphocytic leukemia: effect of estradiol on growth and differentiation in vitro.

  1985cited by this paper
• Estrogen receptors, antibodies and hormone dependent cancer.

  1984cited by this paper
• Better prognosis of many cancers in female: A phenomenon not explained by study of steroid receptors

  1984cited by this paper
• Estrogen receptor analysis in chronic lymphocytic leukemia.

  1983cited by this paper
• A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

  1981cited by this paper
• Clear cell adenocarcinoma and the current status of DES‐exposed females

  1981cited by this paper
• Estrogen receptor assay: interlaboratory and intralaboratory variations in the measurement of receptors using dextran-coated charcoal technique: a study sponsored by E.C.O.G.

  1981cited by this paper
• Estrogen receptor activity in Hodgkin's disease.

  1981cited by this paper
• Estrogen receptors and lymphocytic lymphoma.

  1981cited by this paper
• Estrogen receptor activity in a case of Hodgkin's disease.

  1981cited by this paper
• Androgen, estrogen and progestin binding sites in human leukemic cells

  1981cited by this paper
• Lymphopenic response of patients presenting with chronic lymphocytic leukemia associated with carcinoma of the prostate to diethylstilbestrol: Correlation of response to the in vitro synthesis of rna by patient lymphocytes and its relationship to transcortin

  1980cited by this paper
• Methods of steroid receptor calculation: An interlaboratory study.

  1979cited by this paper
• Clinical staging of chronic lymphocytic leukemia.

  1975cited by this paper
• A human cell line from a pleural effusion derived from a breast carcinoma.

  1973cited by this paper

• Sex-dependent association of circulating sex steroids and pituitary hormones with treatment-free survival in chronic lymphocytic leukemia patients

  2018cites this paper
• The emerging role of estrogen in B cell malignancies

  2017influential citation
• Aberrant Wnt Signaling in Leukemia

  2016cites this paper
• Risk Factors for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Incidence in Postmenopausal Women: a Women’s Health Initiative (WHI) Study

  2016cites this paper
• Non-genomic oestrogen receptor signal in B lymphocytes: An approach towards therapeutic interventions for infection, autoimmunity and cancer.

  2016cites this paper
• Up-regulated estrogen receptor β2 in chronic lymphocytic leukemia

  2012cites this paper
• Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study

  2011cites this paper
• Department of Medicine at Huddinge, Division of Hematology Karolinska Institutet, Stockholm, Sweden CLINICAL PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  2011cites this paper
• Clinical prognostic markers in chronic lymphocytic leukemia

  2011cites this paper
• Female Genital Tract Lymphoma: A Review of Diagnosis and Management

  2009cites this paper
• Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies

  2005cites this paper
• Second neoplasms in patients with chronic lymphocytic leukemia

  2004cites this paper
• Ovarian Non-Hodgkin’s Lymphoma: A Clinicopathologic Study of Eight Primary Cases

  2001cites this paper
• Regulation of estrogen receptor levels by ligand-induced release of compound(s) in MCF-7 cells.

  2000cites this paper
• Sex Steroid Receptors in Hodgkin's Disease

  2000cites this paper
• Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity

  1998cites this paper
• Estrogen does not induce the calcium-dependent nitric oxide synthase in cultured human uterine endothelial and myometrial smooth muscle cells.

  1997cites this paper
• The estrogen receptor CpG island is methylated in most hematopoietic neoplasms.

  1996cites this paper
• Possible effect of medroxyprogesterone acetate (MPA) in lymphoid blast crisis of chronic myelogenous leukemia

  1994cites this paper
• Hormonal Aspects of Lupus: Therapeutic Possibilities

  1993cites this paper
• Hormones and immune responsiveness in chronic lymphocytic leukemia.

  1992cites this paper
• Hormones and Immune Responsiveness Chronic Lymphocytic ieukemia

  1992cites this paper